The resumption of normal purchasing by Ashland Specialty Ingredients is a positive catalyst for near-term revenue. Monitor upcoming quarters for sustained cosmetic ingredient growth and Renacidin market expansion. No guidance was issued, so the next 10-Q will be key for trend confirmation.
Price Chart
Executive Summary
United-Guardian reported Q2 2026 revenue of $3.11M (+10% YoY) and EPS of $0.16 (+14% YoY), driven by a 44% surge in cosmetic ingredient sales as distributor Ashland resumed normal purchasing. Net income rose 16% to $728,579. No forward guidance was provided, but the operating trends are solid for this small-cap specialty manufacturer.
Key Financial Metrics
Key Facts
- Q2 2026 net sales $3,108,267, up 10% from $2,838,225 in Q2 2025
- Net income $728,579 ($0.16 per share), up 16% from $626,826 ($0.14 per share)
- Cosmetic ingredient sales increased 44% in Q2 2026 vs Q2 2025
- Pharmaceutical sales up 1% in Q2; Renacidin remains the key pharmaceutical product
- Operating margin improved to 24.3% from 24.5% (stable); net margin 23.4% vs 22.1%
- No consensus estimates were available for comparison
Financial Impact
Revenue +$270K (+10%), net income +$102K (+16%) YoY; cosmetic ingredient sales drove the growth
Risk Factors
- Concentration risk: Ashland Specialty Ingredients is the largest cosmetic distributor; any inventory normalization could reverse
- Pharmaceutical sales growth was only 1% in Q2, indicating reliance on Renacidin for pharma growth
- Small market cap ($33M) limits liquidity and amplifies volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3341220 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 7, 2026 11w ago | Press Release | $7.29 | awaiting T+60 | — | $6.65 (−8.78%) |
Jul 16, 2026 14w ago | 8-K | $7.50 $7.00 | ▼ −6.67% | ▼ −10.38% | $6.65 (−11.33%) |
May 8, 2026 24w ago | 8-K | $6.87 $7.10 | ▲ +3.35% | ▼ −1.49% | $6.65 (−3.20%) |
May 8, 2026 24w ago | Press Release | $6.87 $7.10 | ▲ +3.35% | ▼ −1.49% | $6.65 (−3.20%) |
Mar 27, 2026 30w ago | Press Release | $6.56 $7.11 | ▼ −8.38% | ▲ +7.68% | $6.65 (−1.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers